author-photo

Belinda M. Dcosta

New York University

12

Papers

263

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Neutralising antibodies against the SARS-CoV-2 Delta variant induced by Alhydroxyquim-II-adjuvanted trimeric spike antigens

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (38)
Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes.

2021 Mbio
Show All
- Source
- Cite
- Save
Citations (18)
Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies.

2021 Mbio
Show All
- Source
- Cite
- Save
Citations (11)
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (72)
SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (15)